This site uses cookies to store information on your computer. Learn more x

Consensus Figures

A number of international financial analysts cover DSM. The most recent consensus figures – provided by Vara Research – are detailed below. The figures are based on the estimates given by the banks that were approached by Vara Research.

Analysts' consensus Q1 2018 and FY 2018 as at 9 March 2018

  Q1 2017 FY 2017 Q1 2018 E FY 2018 E
Sales (continuing)        
Number of Estimates     17 20
Highest     2,293 9,174
Consensus 2,159 8,632 2,235 8,986
Median     2,248 9,005
Lowest     2,184 8,725
Adj. EBITDA (continuing)        
Number of Estimates     17 20
Highest     513 1,700
Consensus 345 1,445 421 1,634
Median     417 1,632
Lowest     384 1,592
Adj. EBIT (continuing)        
Number of Estimates     16 19
Highest     391 1,220
Consensus 222 957 298 1,140
Median     291 1,140
Lowest     268 1,082
Nutrition, Sales        
Number of Estimates     17 20
Highest     1,516 5,999
Consensus 1,398 5,579 1,466 5,835
Median     1,461 5,827
Lowest     1,415 5,602
Nutrition, adj. EBITDA        
Number of Estimates     17 20
Highest     425 1,293
Consensus 257 1,053 324 1,217
Median     321 1,220
Lowest     283 1,160
Nutrition, adj. EBIT        
Number of Estimates     16 17
Highest     349 1,013
Consensus 185 770 250 928
Median     242 934
Lowest     209 863
Materials, Sales        
Number of Estimates     17 20
Highest     740 2,995
Consensus 701 2,825 707 2,912
Median     708 2,907
Lowest     675 2,803
Materials, adj. EBITDA        
Number of Estimates     17 20
Highest     132 524
Consensus 113 488 120 506
Median     119 505
Lowest     112 487
Materials, adj. EBIT        
Number of Estimates     16 17
Highest     99 396
Consensus 81 361 88 376
Median     88 373
Lowest     80 356
Innovation Center, Sales        
Number of Estimates     17 19
Highest     47 186
Consensus 43 169 45 176
Median     45 176
Lowest     42 168
Innovation Center, adj. EBITDA        
Number of Estimates     17 20
Highest     7 24
Consensus 1 9 4 13
Median     4 13
Lowest     1 6
Innovation Center, adj. EBIT        
Number of Estimates     16 17
Highest     2 6
Consensus -5 -30 -4 -18
Median     -5 -21
Lowest     -8 -31
Corporate Activities, Sales        
Number of Estimates     17 19
Highest     22 88
Consensus 17 59 17 63
Median     17 60
Lowest     12 59
Corporate Activities, adj. EBITDA        
Number of Estimates     17 20
Highest     -25 -82
Consensus -26 -105 -26 -103
Median     -26 -105
Lowest     -31 -115
Corporate Activities, adj. EBIT        
Number of Estimates     16 17
Highest     -15 -128
Consensus -39 -144 -35 -144
Median     -36 -144
Lowest     -44 -171
adj. Net Profit for the period, before exceptional items - Cont. Ops.        
Number of Estimates     16 18
Highest     286.3 965.0
Consensus 163.0 706.0 226.9 860.1
Median     221.5 851.2
Lowest     199.0 802.0
adj. Net EPS before exceptional items - Cont. Ops.        
Number of Estimates     16 18
Highest     1.64 5.51
Consensus 0.92 3.92 1.28 4.84
Median     1.26 4.82
Lowest     1.11 4.47

Disclaimer
Consensus earnings estimates are based on earnings projections made by securities analysts who cover DSM. Any opinions, forecasts, estimates, projections or predictions regarding DSM’s performance made by the analysts (and, therefore, the Consensus estimate numbers) are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of DSM or its management. DSM does not by providing these estimates imply its endorsement of or concurrence with such information, conclusions or recommendations. DSM assumes no liability for the accuracy of such estimates and undertakes no obligation to update or revise such estimates.